Latest Breaking News On - Shanghai dahua pharmaceutical co ltd - Page 2 : comparemela.com

(0) Despite global disruptions to family planning services due to the Covid-19 pandemic, WomanCare Global Trading CIC (DKT WomanCare) and Shanghai Dahua Pharmaceutical Co., Ltd. (Dahua) are proud to announce a price reduction of Levoplant, a two-rod contraceptive implant prequalified by the World Health Organization (WHO) for up to three years of use. Levoplant is currently registered and increasing the reproductive health autonomies of women in more than 30 countries around the world. Levoplant will now be just $6.70 USD (FOB) for qualified purchasers in FP2020 focus countries, a $0.20 decrease from the current access price of $6.90 USD and the second such reduction over the last three years. Despite Covid-19 and a general climate of significant cost increases across the pharmaceutical industry, especially for raw materials like levonorgestrel (the active pharmaceutical ingredient in Levoplant), this price reduction will help expand access to a quality contraceptive to those th

United kingdomJacques antoine martinKostenloser wertpapierhandelChris purdyKatherine ladnerShanghai dahua pharmaceutical co ltdUnited nations population fundWorld health organizationCommonwealth development officeWomancare global tradingRobin songGeneral managerUnited nations populationManaging directorCare globalஒன்றுபட்டது கிஂக்டம்